Tower Research Capital LLC (Trc) Aura Biosciences, Inc. Transaction History
Tower Research Capital LLC (Trc)
- $3.68 Billion
- Q3 2024
A detailed history of Tower Research Capital LLC (Trc) transactions in Aura Biosciences, Inc. stock. As of the latest transaction made, Tower Research Capital LLC (Trc) holds 2,699 shares of AURA stock, worth $21,942. This represents 0.0% of its overall portfolio holdings.
Number of Shares
2,699
Previous 4,682
42.35%
Holding current value
$21,942
Previous $35,000
31.43%
% of portfolio
0.0%
Previous 0.0%
Shares
12 transactions
Others Institutions Holding AURA
# of Institutions
85Shares Held
37.6MCall Options Held
122KPut Options Held
38.5K-
Matrix Capital Management Company, LP Waltham, MA6.92MShares$56.3 Million2.94% of portfolio
-
Eventide Asset Management, LLC Boston, MA5.8MShares$47.2 Million0.91% of portfolio
-
Adage Capital Partners Gp, L.L.C. Boston, MA4.88MShares$39.7 Million0.08% of portfolio
-
Medicxi Ventures Management (Jersey) LTD3.04MShares$24.7 Million5.63% of portfolio
-
Black Rock Inc. New York, NY3.01MShares$24.4 Million0.0% of portfolio
About Aura Biosciences, Inc.
- Ticker AURA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 29,273,600
- Market Cap $238M
- Description
- Aura Biosciences, Inc. operates as a biotechnology company that develops therapies to treat cancer. The company develops virus-like drug conjugates (VDC) technology platform for the treat tumors of high unmet need in ocular and urologic oncology. It develops AU-011, a VDC candidate for the treatment of primary choroidal melanoma. It also develop...